share_log

騰盛博藥-B:董事會召開日期

BRII-B: DATE OF BOARD MEETING

Hong Kong Stock Exchange ·  Aug 5 04:43
Summary by Moomoo AI
騰盛博藥生物科技有限公司(「腾盛博药-B」)宣布,公司董事會將於2024年8月19日(星期一)召開會議,主要目的是審閱及批准發佈截至2024年6月30日止六個月的未經審核中期業績。會議將由董事會主席Zhi Hong博士主持,並將處理其他事項。董事會成員包括執行董事Zhi Hong博士及李安康博士,以及獨立非執行董事Martin J Murphy Jr博士、Grace Hui Tang女士、徐耀華先生、Gregg Huber Alton先生及楊台瑩博士。
騰盛博藥生物科技有限公司(「腾盛博药-B」)宣布,公司董事會將於2024年8月19日(星期一)召開會議,主要目的是審閱及批准發佈截至2024年6月30日止六個月的未經審核中期業績。會議將由董事會主席Zhi Hong博士主持,並將處理其他事項。董事會成員包括執行董事Zhi Hong博士及李安康博士,以及獨立非執行董事Martin J Murphy Jr博士、Grace Hui Tang女士、徐耀華先生、Gregg Huber Alton先生及楊台瑩博士。
Tengshengbo Pharmaceutical Bio-Technology Co., Ltd. ('Tengshengbo Medicine-B') announced that the board of directors will hold a meeting on August 19, 2024 (Monday) to review and approve the unaudited interim performance report for the six months ended June 30, 2024. The meeting will be chaired by Dr. Zhi Hong, chairman of the board of directors, and other matters will be dealt with. Board members include executive directors Dr. Zhi Hong and Dr. Li An Kang, as well as independent non-executive directors Dr. Martin J Murphy Jr., Ms. Grace Hui Tang, Mr. Xu Yaohua, Mr. Gregg Huber Alton and Dr. Yang Taiying.
Tengshengbo Pharmaceutical Bio-Technology Co., Ltd. ('Tengshengbo Medicine-B') announced that the board of directors will hold a meeting on August 19, 2024 (Monday) to review and approve the unaudited interim performance report for the six months ended June 30, 2024. The meeting will be chaired by Dr. Zhi Hong, chairman of the board of directors, and other matters will be dealt with. Board members include executive directors Dr. Zhi Hong and Dr. Li An Kang, as well as independent non-executive directors Dr. Martin J Murphy Jr., Ms. Grace Hui Tang, Mr. Xu Yaohua, Mr. Gregg Huber Alton and Dr. Yang Taiying.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more